166 related articles for article (PubMed ID: 38581008)
21. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
Front Oncol; 2022; 12():938679. PubMed ID: 35982954
[TBL] [Abstract][Full Text] [Related]
22. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
23. High Expression of CHST11 Correlates with Poor Prognosis and Tumor Immune Infiltration of Pancreatic Cancer.
Zhang P; Chen D; Cui H; Luo Q
Clin Lab; 2022 Dec; 68(12):. PubMed ID: 36546737
[TBL] [Abstract][Full Text] [Related]
24. LncRNAs associated with vascular mimicry establish a novel molecular subtype and prognostic model for pancreatic cancer.
Li D; Zhang Q; Tang Y; Mao F; Zeng J; Ji A
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11571-11584. PubMed ID: 37400573
[TBL] [Abstract][Full Text] [Related]
25. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
26. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings.
Zhu S; Zhao Q; Fan Y; Tang C
BMC Urol; 2023 Dec; 23(1):199. PubMed ID: 38049825
[TBL] [Abstract][Full Text] [Related]
27. NLRP12 is a prognostic biomarker and correlated with immune infiltrates in epithelial ovarian cancer.
Ma R; Tang Z; Wang J
J Gene Med; 2024 Jan; 26(1):e3585. PubMed ID: 37926491
[TBL] [Abstract][Full Text] [Related]
28. Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape.
Liu H; Li Z; Zhang L; Zhang M; Liu S; Wang J; Yang C; Peng Q; Du C; Jiang N
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371833
[TBL] [Abstract][Full Text] [Related]
29. EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway.
Xu J; Zhang W
Cancer Cell Int; 2021 Oct; 21(1):521. PubMed ID: 34627255
[TBL] [Abstract][Full Text] [Related]
30. FNDC3B, Targeted by miR-125a-5p and miR-217, Promotes the Proliferation and Invasion of Colorectal Cancer Cells via PI3K/mTOR Signaling.
Li Y; Yang J; Wang H; Qiao W; Guo Y; Zhang S; Guo Y
Onco Targets Ther; 2020; 13():3501-3510. PubMed ID: 32431508
[TBL] [Abstract][Full Text] [Related]
31. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
32. Integrated analysis identifies S100A16 as a potential prognostic marker for pancreatic cancer.
Chen T; Xia DM; Qian C; Liu SR
Am J Transl Res; 2021; 13(5):5720-5730. PubMed ID: 34150181
[TBL] [Abstract][Full Text] [Related]
33. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
[TBL] [Abstract][Full Text] [Related]
34. CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma.
Liang X; Song F; Fang W; Zhang Y; Feng Z; Chen Z; Han L; Chen Z
Int J Gen Med; 2022; 15():5661-5672. PubMed ID: 35734199
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancer.
Ke MJ; Ji LD; Li YX
Cancer Cell Int; 2020; 20():382. PubMed ID: 32782440
[TBL] [Abstract][Full Text] [Related]
36. CircSOS2 promotes cervical squamous cell carcinoma by regulation of proliferation, cell cycle, apoptosis, migration, invasion, and glycolysis by targeting miR-543/FNDC3B axis.
Li Y; Tang Y; Li Z; Hou G; Du X
Arch Biochem Biophys; 2021 Sep; 708():108925. PubMed ID: 34023283
[TBL] [Abstract][Full Text] [Related]
37. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
38. S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer.
Chen Y; Wang C; Song J; Xu R; Ruze R; Zhao Y
Front Immunol; 2021; 12():758004. PubMed ID: 34887861
[TBL] [Abstract][Full Text] [Related]
39. Hsa_circRNA_0001971 contributes to oral squamous cell carcinoma progression via miR-186-5p/Fibronectin type III domain containing 3B axis.
Zhang J; Peng Y; Jiang S; Li J
J Clin Lab Anal; 2022 Mar; 36(3):e24245. PubMed ID: 35060189
[TBL] [Abstract][Full Text] [Related]
40. Identification of
Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
Front Genet; 2022; 13():810292. PubMed ID: 35368661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
